Jitendra Kumar Trivedi
King George's Medical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jitendra Kumar Trivedi.
Indian Journal of Psychiatry | 2006
Jitendra Kumar Trivedi
Cognition denotes a relatively high level of processing of specific information including thinking, memory, perception, motivation, skilled movements and language. Cognitive psychology has become an important discipline in the research of a number of psychiatric disorders, ranging from severe psychotic illness such as schizophrenia to relatively benign, yet significantly disabling, non-psychotic illnesses such as somatoform disorder. Research in the area of neurocognition has started unlocking various secrets of psychiatric disorders, such as revealing the biological underpinnings, explaining the underlying psychopathology and issues related to course, outcome and treatment strategies. Such research has also attempted to uproot a number of previously held concepts, such as Kraepelins dichotomy. Although the range of cognitive problems can be diverse, there are several cognitive domains, including executive function, attention and information processing, and working memory, which appear more frequently at risk. A broad range of impairment across and within the psychiatric disorders are highlighted in this oration. The oration summarizes the studies investigating cognitive processing in different psychiatric disorders. I will also discuss the findings of my own research on neurocognitive deficits in mood disorders, schizophrenia, obsessive–compulsive disorder, somatoform disorder, including studies on ‘high-risk’ individuals. Tracing the evaluation of neurocognitive science may provide new insights into the pathophysiology and treatment of psychiatric disorders.
Pharmacopsychiatry | 2012
Yu Tao Xiang; Chun-Xue Wang; Tian-Mei Si; Edwin Ho Ming Lee; Yanling He; G. S. Ungvari; Helen F.K. Chiu; Shu-Yu Yang; M.-Y. Chong; Chay Hoon Tan; Ee Heok Kua; Senta Fujii; Kang Sim; K. H. Yong; Jitendra Kumar Trivedi; Eun-Kee Chung; Pichet Udomratn; Kok-Yoon Chee; Norman Sartorius; Naotaka Shinfuku
OBJECTIVE This study aimed to identify trends in the use of antipsychotic polypharmacy (APP) and their demographic and clinical correlates in the treatment of schizophrenia in Asia between 2001 and 2009. METHOD A total of 6,761 schizophrenia inpatients in 9 Asian countries and territories were examined; 2,399 in 2001, 2,136 in 2004, and 2,226 in 2009. Patients’ socio-demographic and clinical characteristics and prescriptions of psychotropic drugs were recorded using a standardized protocol and data collection procedure. RESULTS The proportion of APP prescription decreased from 46.8 % in 2001, to 38.3 % in 2004, and increased to 43.4 % in 2009, with wide intercountry variations at each survey. Multiple logistic regression analysis of the whole sample revealed that patients on APP were younger, had a higher dose of antipsychotics in chlorpromazine equivalents, and more severe positive and negative symptoms. They were also more likely to receive depot and fi rst-generation antipsychotic drugs. CONCLUSIONS The frequency of APP prescription varied between countries and territories, suggesting that a host of clinical and socio-cultural factors played a role in determining APP use in Asia. To resolve the discrepancy between treatment recommendation and clinical practice, regular reviews of prescription patterns are needed.
Psychiatry and Clinical Neurosciences | 2008
Jitendra Kumar Trivedi; Dishanter Goel; Mohan Dhyani; Sachin Sharma; Anand Pratap Singh; Pramod Kumar Sinha; Rajul Tandon
Aim: Cognitive deficits have been presupposed to be endophenotypic markers in bipolar disorder, but few studies have ascertained the cognitive deficits in healthy relatives of bipolar disorder patients. The aim of the present study was to assess the cognitive functions of first‐degree relatives of patients with bipolar disorder and compare them with healthy controls.
Indian Journal of Psychiatry | 2008
Jitendra Kumar Trivedi; Himanshu Sareen; Mohan Dhyani
Rapid increase in urban population as a proportion of total population is resulting in rapid urbanization of the world. By the end of 2008, a majority of the worlds population will be living in the cities. This paradigm shift in the dynamics of human population is attracting attention of demographers, sociologists, scientists, and politicians alike. Urbanization brings with it a unique set of advantages and disadvantages. Though it is driving the economies of most of the nations of the world, a serious concern regarding the impact of urbanization on mental health is warranted. The impact of urbanization on mental health in South-Asian countries needs to be examined. These countries by virtue of their developing economies and a significant proportion of population still living below poverty line are particularly vulnerable and tend to have a higher burden of diseases with an already compromised primary health care delivery system. The range of disorders and deviancies associated with urbanization is enormous and includes psychoses, depression, sociopathy, substance abuse, alcoholism, crime, delinquency, vandalism, family disintegration, and alienation. Thus, it is a heterogenous mix of problems and categorizing them to one particular subtype seems daunting and undesirable. Urbanization is affecting the entire gamut of population especially the vulnerable sections of society - elderly, children and adolescents, and women. Rapid urbanization has also led to creation of “fringe population” mostly living from hand to mouth which further adds to poverty. Poverty and mental health have a complex and multidimensional relationship. Urban population is heavily influenced by changing cultural dynamics leading to particular psychiatric problems like depression, alcoholism, and delinquency. Judicious use of resources, balanced approach to development, and sound government policies are advocated for appropriate growth of advancing economies of South-Asian region.
World Psychiatry | 2009
Oye Gureje; Sheila Hollins; Michel Botbol; Afzal Javed; Miguel Roberto Jorge; Violet Okech; Michelle Riba; Jitendra Kumar Trivedi; Norman Sartorius; Rachel Jenkins
The brain drain of health professionals is an issue of continuing interest and debate. The WPA set up a Task Force to examine the phenomenon as it relates specifically to mental health professionals. This report provides a description of the work of the Task Force and its recommendations in regard to how the WPA might act to help address the issue.
Mens Sana Monographs | 2009
Jitendra Kumar Trivedi; Himanshu Sareen; Mohan Dhyani
Despite advances in standard of living of the population, the condition of widows and divorced women remains deplorable in society. The situation is worse in developing nations with their unique social, cultural and economic milieu, which at times ignores the basic human rights of this vulnerable section of society. A gap exists in life expectancies of men and women in both developing and developed nations. This, coupled with greater remarriage rates in men, ensures that the number of widows continues to exceed that of widowers. Moreover, with women becoming more educated, economically independent and aware of their rights, divorce rates are increasing along with associated psychological ramifications. The fact that widowed/divorced women suffer from varying psychological stressors is often ignored. It has been concluded in various studies that such stressors could be harbingers of psychiatric illnesses (e.g., depression, anxiety, substance dependence), and hence should be taken into account by treating physicians, social workers and others who come to the aid of such women. A change in mindset of the society is required before these women get their rightful place, for which a strong will is needed in the minds of the people, and in law-governing bodies.
Australian and New Zealand Journal of Psychiatry | 2011
Yu-Tao Xiang; Chuan-Yue Wang; Tian-Mei Si; Edwin Ho Ming Lee; Yanling He; Gabor S. Ungvari; Helen F.K. Chiu; Naotaka Shinfuku; Shu-Yu Yang; Mian-Yoon Chong; Ee Heok Kua; Senta Fujii; Kang Sim; Michael K.H. Yong; Jitendra Kumar Trivedi; Eun-Kee Chung; Pichet Udomratn; Kok-Yoon Chee; Norman Sartorius; Lisa B. Dixon; Julie Kreyenbuhl; Chay Hoon Tan
Objective: Optimizing treatment and outcomes for people with schizophrenia requires understanding of how evidence-based treatments are utilized. Clozapine is the most effective antipsychotic drug for treatment-refractory schizophrenia, but few studies have investigated trends and patterns of its use over time internationally. This study examined the prescription patterns of clozapine and its demographic and clinical correlates in Asia from 2001 to 2009. Method: Clozapine prescriptions were collected in a sample of 6761 hospitalized schizophrenia patients in nine Asian countries and regions using a standardized protocol and data collection procedure. Results: Overall, the proportion of patients receiving clozapine prescriptions was stable across the three surveys from 2001 to 2009, ranging from 14.5% to 15.9%. However, the rates and patterns observed within different regions and countries at each survey differed considerably. Clozapine use decreased significantly over time in China, while it increased in Korea and Singapore. Multiple logistic regression analysis revealed that patients taking clozapine were significantly younger, had a higher dose of antipsychotic drugs in chlorpromazine equivalents, were more likely to be female, had fewer extrapyramidal symptoms, and had more negative symptoms, admissions and weight gain in the past month than those not receiving clozapine. Conclusion: The variability in overall rates and changes in prescription rates over time in these samples suggest that factors other than psychopharmacological principles play an important role in determining the use of clozapine in schizophrenia in Asia.
Cognitive Neuropsychiatry | 2008
Jitendra Kumar Trivedi; Mohan Dhyani; Sachin Sharma; Pramod Kumar Sinha; Anand Pratap Singh; Rajul Tandon
Introduction. It has recently been observed that some cognitive deficits in bipolar disorders persist even after the subsidence of active symptoms. The authors aim to study the cognitive functioning of patients with bipolar disorder, currently in euthymia and compare them with normal healthy controls. Methods. Fifteen patients having bipolar-I disorder and currently in euthymia were compared with fifteen age- and education-matched controlled subjects. Cognitive assessments were done using three computer-based tests, i.e., Wisconsins Card Sorting Test (WCST), Spatial Working Memory Test (SWMT), and Continuous Performance Test (CPT). Results. Euthymic bipolar patients showed significant deficits in executive functions. Subtle deficits were present in attention and working memory that were not statistically significant. Conclusions. Executive deficits may be trait markers in bipolar disorder and may have clinical implications in patient rehabilitation.
Psychiatry and Clinical Neurosciences | 2015
Yu-Tao Xiang; Gabor S. Ungvari; Christoph U. Correll; Helen F.K. Chiu; Kelly Y. C. Lai; Chuan-Yue Wang; Tian-Mei Si; Edwin Ho Ming Lee; Yanling He; Shu-Yu Yang; Mian-Yoon Chong; Ee Heok Kua; Senta Fujii; Kang Sim; Michael K.H. Yong; Jitendra Kumar Trivedi; Eun-Kee Chung; Pichet Udomratn; Kok-Yoon Chee; Norman Sartorius; Chay Hoon Tan; Naotaka Shinfuku
Little is known about electroconvulsive therapy (ECT) use in Asian inpatients with schizophrenia. This study examined trends of ECT use for schizophrenia patients in Asia between 2001 and 2009 and its independent demographic and clinical correlates.
International Journal of Geriatric Psychiatry | 2014
Yu-Tao Xiang; Yan Li; Christoph U. Correll; Gabor S. Ungvari; Helen F.K. Chiu; Kelly Y. C. Lai; Quan-Sheng Tang; Wei Hao; Tian-Mei Si; Chuan-Yue Wang; Edwin Ho Ming Lee; Yanling He; Shu-Yu Yang; Mian-Yoon Chong; Ee Heok Kua; Senta Fujii; Kang Sim; Michael K.H. Yong; Jitendra Kumar Trivedi; Eun-Kee Chung; Pichet Udomratn; Kok-Yoon Chee; Norman Sartorius; Chay Hoon Tan; Naotaka Shinfuku
This study aimed to examine the use of high doses of antipsychotic medications (≥600 mg/day chlorpromazine equivalent) in older Asian patients with schizophrenia and its demographic and clinical correlates.